Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.

Martin A, Scahill L, Klin A, Volkmar FR.

J Am Acad Child Adolesc Psychiatry. 1999 Jul;38(7):923-31.

PMID:
10405512
2.

[Non-autistic pervasive developmental disorders: Rett syndrome, disintegrative disorder and pervasive developmental disorder not otherwise specified].

Mercadante MT, Van der Gaag RJ, Schwartzman JS.

Rev Bras Psiquiatr. 2006 May;28 Suppl 1:S12-20. Review. Portuguese.

3.

Pharmacotherapy of irritability in pervasive developmental disorders.

Stigler KA, McDougle CJ.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002. Review.

PMID:
18775367
4.

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Posey DJ, McDougle CJ.

Harv Rev Psychiatry. 2000 Jul-Aug;8(2):45-63. Review.

PMID:
10902094
5.

[Diagnostic criteria of autism and Asperger's syndrome: similarities and differences].

Poirier N, Forget J.

Sante Ment Que. 1998 Spring;23(1):130-48. Review. French.

PMID:
9775958
6.

[Prevalence of pervasive developmental disorders. A review].

Lenoir P, Bodier C, Desombre H, Malvy J, Abert B, Ould Taleb M, Sauvage D.

Encephale. 2009 Feb;35(1):36-42. doi: 10.1016/j.encep.2007.12.011. Review. French.

PMID:
19250992
7.

A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders.

Simeon J, Milin R, Walker S.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Feb;26(2):267-75. Review.

PMID:
11817503
8.

Pathological demand avoidance syndrome: a necessary distinction within the pervasive developmental disorders.

Newson E, Le Maréchal K, David C.

Arch Dis Child. 2003 Jul;88(7):595-600. Review.

9.

[Sixty years of autism].

van Berckelaer-Onnes IA.

Ned Tijdschr Geneeskd. 2004 May 22;148(21):1024-30. Review. Dutch.

PMID:
15185436
10.

Asperger's syndrome: diagnosis, treatment, and outcome.

Szatmari P.

Psychiatr Clin North Am. 1991 Mar;14(1):81-93. Review.

PMID:
2047334
12.

[Review of psychopharmacological treatments in adolescents and adults with autistic disorders].

Baghdadli A, Gonnier V, Aussilloux C.

Encephale. 2002 May-Jun;28(3 Pt 1):248-54. Review. French.

PMID:
12091786
13.

Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.

Hamrin V, McDonnell MA, Moffett J, Durso S.

Minerva Pediatr. 2008 Feb;60(1):87-101. Review.

PMID:
18277368
14.
15.

[Medical treatment of pervasive developmental disorders].

Fuentes J, Gallano I.

Rev Neurol. 2001 Aug 1-15;33(3):208-10. Review. Spanish.

PMID:
11588711
16.

[Current status of autism studies].

Kurita H.

Seishin Shinkeigaku Zasshi. 2001;103(1):64-75. Review. Japanese.

PMID:
11383012
17.

An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders.

Geier DA, Kern JK, King PG, Sykes LK, Geier MR.

Acta Neurobiol Exp (Wars). 2012;72(1):1-17. Review.

18.

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Wink LK, Plawecki MH, Erickson CA, Stigler KA, McDougle CJ.

Expert Opin Emerg Drugs. 2010 Sep;15(3):481-94. doi: 10.1517/14728214.2010.487860. Review.

19.

Cognitive-adaptive disabilities.

Calles JL Jr.

Pediatr Clin North Am. 2011 Feb;58(1):189-203, xii. doi: 10.1016/j.pcl.2010.10.003. Review.

PMID:
21281856
20.

Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice.

Siegel M, Beaulieu AA.

J Autism Dev Disord. 2012 Aug;42(8):1592-605. doi: 10.1007/s10803-011-1399-2. Review.

PMID:
22068820

Supplemental Content

Support Center